Search - tctmd.com

Displaying 41 - 60 of 487

Sort: Relevancy | Date

News Conference News CRT 2024

Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries

L.A. McKeown

March 14, 2024

News Conference News CRT 2024

Full AGENT IDE Results Affirm Benefits of DCB for In-Stent Restenosis

L.A. McKeown

March 09, 2024

News Daily News

Agent Coronary DCB Gets FDA Approval for In-Stent Restenosis

L.A. McKeown

March 01, 2024

Presentation Miami Valves 2024

Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis

Presenter: Thomas E. Noel

February 01, 2024

News Daily News

Top Endovascular News of 2023

L.A. McKeown

December 28, 2023

News Conference News TCT 2023

Sirolimus- and Paclitaxel-Coated Balloons Well-Matched for In-Stent Restenosis

Todd Neale

November 02, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2023

Shelley Wood

November 01, 2023

Presentation TCT 2023

TCT 476: Biological Differences of Three Paclitaxel- and Sirolimus-coated Balloons on Coronary Lesions in a Rabbit Model

Presenter: Kazuki Aihara

October 25, 2023

Presentation TCT 2023

TCT 128: Treatment of Coronary Artery Disease with Sirolimus- Versus Paclitaxel-Coated Balloons

Presenter: Matthias Bossard

October 25, 2023

Presentation TCT 2023

Prevail Paclitaxel Coated Balloon

Presenter: Jack Tan

October 25, 2023

Presentation TCT 2023

TCT 743: Long-term Clinical Outcomes of Paclitaxel-Coated Balloon Coronary Angioplasty: Data from the IRIS-DEB Registry

Presenter: Young-Sun Park

October 25, 2023

News Conference News TCT 2023

Comparing DCBs in De Novo CAD: Drugs, Design Matter

Caitlin E. Cox

October 25, 2023

News Conference News TCT 2023

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

Todd Neale

October 25, 2023

Presentation TCT 2023

TCT 286: Comparison of Downstream Effect and Arterial Responses Among Sirolimus- and Paclitaxel-coated Balloons in Swine Heart Model

Presenter: Teruo Sekimoto

October 25, 2023

News Conference News TCT 2023

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

L.A. McKeown

October 24, 2023

News Opinion Editor's Corner

What’s Going to Be Hot at TCT 2023

Shelley Wood

October 19, 2023

News Daily News

FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed

L.A. McKeown

July 11, 2023

News Conference News LINC 2023

PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD

L.A. McKeown

June 21, 2023

News Industry News

Concept Medical’s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

June 01, 2023

News Daily News

Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis

Michael O'Riordan

February 24, 2023

Advertisement

Mixed Bag With DCBs for In-Stent Restenosis, Small Coronary Arteries

Full AGENT IDE Results Affirm Benefits of DCB for In-Stent Restenosis

Agent Coronary DCB Gets FDA Approval for In-Stent Restenosis

Multicenter Randomized Trial Comparing the AGENT Paclitaxel-Coated Balloon With Conventional Balloon Angioplasty for In-Stent Restenosis

Top Endovascular News of 2023

Sirolimus- and Paclitaxel-Coated Balloons Well-Matched for In-Stent Restenosis

TCTMD’s Top 10 Most Popular Stories for October 2023

TCT 476: Biological Differences of Three Paclitaxel- and Sirolimus-coated Balloons on Coronary Lesions in a Rabbit Model

TCT 128: Treatment of Coronary Artery Disease with Sirolimus- Versus Paclitaxel-Coated Balloons

Prevail Paclitaxel Coated Balloon

TCT 743: Long-term Clinical Outcomes of Paclitaxel-Coated Balloon Coronary Angioplasty: Data from the IRIS-DEB Registry

Comparing DCBs in De Novo CAD: Drugs, Design Matter

‘Light at the End of the Tunnel’ for In-Stent Restenosis: AGENT IDE Wins Big

TCT 286: Comparison of Downstream Effect and Arterial Responses Among Sirolimus- and Paclitaxel-coated Balloons in Swine Heart Model

Paclitaxel Safety Questions in PAD: Will ‘Capstone’ Data Close the Door?

What’s Going to Be Hot at TCT 2023

FDA: All Restrictions on Paclitaxel Devices for PAD Are Removed

PROSPECT MONSTER: Real-World Data Confirm Low-Dose DCB Efficacy in PAD

Concept Medical’s fourth IDE approval for the MagicTouch Sirolimus Coated Balloon is granted for the treatment of Superficial Femoral Artery Disease (SFA)

Long-term Data Support Paclitaxel-Coated Balloons for In-Stent Restenosis

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content